Nestle, probiotic supplier sign global deal
September 02, 2008
by Jeff Gelski
Nestle Nutrition may use the patented probiotic Lactobacillus reuteri from BioGaia AB, a Stockholm, Sweden-based biotechnology company, in its infant formula in world markets, excluding Japan and South Korea, according to an agreement between the two companies announced Aug. 21. Nestle already uses the probiotic in formula products in some European and Asian countries.
"We look forward to a long-term and mutually beneficial cooperation with Nestle in children’s probiotics and expect volumes to grow and become a significant part of BioGaia’s future business," said Peter Rothschild, president of BioGaia AB. "The company already has an agreement with Nestle Nutrition in the area of health care nutrition."
On June 9 BioGaia AB made a Generally Recognized as Safe (GRAS) filing with the U.S. Food and Drug Administration for the use of Lactobacillus reuteri strain DSM 17938 as an ingredient in processed cheeses, yogurt, ice cream, fruit juices, fruit drinks, beverage bases, energy bars, energy drinks and chewing gum. The filing was pending as of Aug. 26.
For more information, visit www.biogaia.com.
This article can also be found in the digital edition of Food Business News, September 2, 2008, starting on Page 56. Click
to search that archive.